Scarica l'app Stockscreener
6.58
1.64%
-0.11
Dopo l'orario di chiusura:
6.60
0.02
+0.30%
Panoramica
Notizia
Cronologia dei prezzi
Financials
Perché AVTX Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$6.69
Aprire:
$6.6
Volume 24 ore:
59,982
Relative Volume:
0.65
Capitalizzazione di mercato:
$71.25M
Reddito:
$1.93M
Utile/perdita netta:
$-7.96M
Rapporto P/E:
-0.00186
EPS:
-3530.8178
Flusso di cassa netto:
$-36.78M
1 W Prestazione:
-2.23%
1M Prestazione:
+37.66%
6M Prestazione:
-18.16%
1 anno Prestazione:
-42.98%
Intervallo 1D:
$6.58
$6.8882
Intervallo di 1 settimana:
$6.3551
$6.9255
Portata 52W:
$3.39
$16.00
Avalo Therapeutics Inc Stock (AVTX) Company Profile
Nome
Avalo Therapeutics Inc
Settore
Industria
Telefono
410-522-8707
Indirizzo
1500 LIBERTY RIDGE DRIVE, WAYNE
Confronta AVTX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AVTX
Avalo Therapeutics Inc
|
6.58 | 72.44M | 1.93M | -7.96M | -36.78M | -3,530.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.83 | 120.60B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.63 | 60.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
324.79 | 42.87B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
595.19 | 36.23B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
294.51 | 31.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Avalo Therapeutics Inc Stock (AVTX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-02 | Ripresa | H.C. Wainwright | Buy |
| 2025-03-25 | Iniziato | Jefferies | Buy |
| 2025-03-25 | Iniziato | Stifel | Buy |
| 2025-02-28 | Iniziato | Piper Sandler | Overweight |
| 2025-02-21 | Iniziato | Wedbush | Outperform |
| 2024-12-19 | Iniziato | BTIG Research | Buy |
| 2024-10-24 | Iniziato | H.C. Wainwright | Neutral |
| 2024-04-16 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2021-09-24 | Iniziato | RBC Capital Mkts | Outperform |
Mostra tutto
Avalo Therapeutics Inc Borsa (AVTX) Ultime notizie
What are analysts’ price targets for Avalo Therapeutics Inc. in the next 12 monthsBest Dividend Tips With High Returns - jammulinksnews.com
What institutions are buying Avalo Therapeutics Inc. stock nowShort Term High Yield Stock Tips for Active Traders - metal.it
What are the technical indicators suggesting about Avalo Therapeutics Inc.Invest confidently with real-time market updates - jammulinksnews.com
How to forecast Avalo Therapeutics Inc. trends using time seriesHigh Return Idea With Technical Filter - Newser
Real time pattern detection on Avalo Therapeutics Inc. stockFree Chart Alert System With Entry Targets - Newser
Is Avalo Therapeutics Inc. still worth holding after the dip Free Stable Entry High Return Opportunities - Newser
What is Avalo Therapeutics Inc. company’s growth strategyFree Consultation - jammulinksnews.com
What is the dividend policy of Avalo Therapeutics Inc. stockBuild a portfolio that delivers consistent profits - jammulinksnews.com
Moving Average Trends for Avalo Therapeutics Inc. Stock: What They IndicateFree Access to Community with 300% Return - Newser
Buy Signal for Avalo Therapeutics Inc. Stock Key Technical Indicators to WatchSteady Profit Stock Forecasts - Newser
Why Avalo Therapeutics Inc. stock attracts strong analyst attentionWatchlist Winner Update - Newser
What analysts say about Avalo Therapeutics Inc. stockSky-high profits - PrintWeekIndia
What drives Avalo Therapeutics Inc. stock priceHigh-yield investments - PrintWeekIndia
Avalo Therapeutics Inc. Stock Analysis and ForecastAccelerated capital growth - PrintWeekIndia
When is the best time to buy Avalo Therapeutics Inc. stockExponentially increasing returns - jammulinksnews.com
Is Avalo Therapeutics Inc. a good long term investmentSkyrocketing returns - jammulinksnews.com
Stifel reiterates Buy rating on Avalo Therapeutics stock, maintains $36 target - Investing.com India
Stifel reiterates Buy rating on Avalo Therapeutics stock, maintains $36 target By Investing.com - Investing.com South Africa
Avalo Therapeutics Soars 10.66% on Bullish Sentiment - AInvest
Avalo Therapeutics (AVTX) Soars 10.42% on Analyst Upgrade - AInvest
What makes Avalo Therapeutics Inc. stock attractive to long term investorsBalanced Risk Reward Portfolio - Newser
Does Avalo Therapeutics Inc. stock pay reliable dividendsReal Time Alert Service - Newser
What makes Avalo Therapeutics Inc. stock price move sharplyBreakout Confirmation Tool - Newser
How Avalo Therapeutics Inc. stock performs during market volatilityVolume Spike Monitors - Newser
Avalo Therapeutics Inc Azioni (AVTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.32%
1.06%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):